Submitted by olivier.jacqmain on Fri, 07/20/2012 - 16:54
With its latest round of funding complete, the International Diabetes Federation’s translational research programme, BRIDGES, has raised its game again, receiving 57 applications from 32 countries. This round of financial support ensured USD 65,000 per project and was dedicated to short-term projects lasting a maximum two years. Having undergone rigorous screening by recognized experts, nine of the projects were selected and will benefit from financial backing from IDF. Ronan L’Heveder describes the latest innovative projects to quality for BRIDGES funding.
Submitted by olivier.jacqmain on Fri, 07/20/2012 - 16:50
In 2011, the Royal Prince Alfred Hospital Diabetes Centre in Sydney, Australia, joined the voluntary network of International Diabetes Federation (IDF) Centres of Education. There are currently eight such centres providing excellent diabetes care and education services in Latin America, Asia (including the Indian sub-continent and China), Europe and now Australia. Central to the aims of the Centres of Education are efforts to increase regional capacity to respond to the diabetes epidemic.
Submitted by valerie.eijrond on Mon, 04/16/2012 - 15:44
Issues relating to people with diabetes injecting themselves with insulin quite rightly are an important focus of diabetes care. Concerns include avoiding the complications of inaccurate dosing, and ensuring the proper care of injection sites and correct use of blood glucose selfmonitoring. The current implementation of the 2010 EU Directive on sharps injury prevention, places the spotlight of attention on the safety and protection of healthcare professionals when they are administering treatment to people with diabetes. Questions arise over the risks to the diabetes specialist.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 17:22
China is experiencing an increase in the number of people with type 1 diabetes. New cases as well as improved life expectancy among people with established diabetes are behind the rising prevalence. The incidence of type 1 diabetes among children has been put at 0.59 per 100,000 people per year. Although this is farlower than in some other regions, such as northern Europe, our numbers are huge because China has such a large population – in excess of 1.3 billion.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 17:17
Successful implementation of structured education programmes that teach people with type 1 diabetes to use insulin flexibly around normal
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 17:14
Two English diabetologists were among an international audience while Michael Berger told it to throw away the diet from the therapeutic approach
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:22
Australian diabetes healthcare professionals in Melbourne learned about the DAFNE programme for people with type 1 diabetes in 2004, during a visit to the International Diabetes Institute there by Stephanie Amiel. Rather like the UK teams a few years earlier, a teamof nine health professionals from four Australian centres undertook DAFNE training in the UK that year. Prior to this, there were no evidence-based group programmes providing structured education for people with type 1 in Australia.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:17
There is overwhelming evidence that improving HbA1c reduces the risk of longterm complications and improves quality of life. In Kuwait, however, few people with diabetes reach their target levels and, as a consequence, remain at risk of diabetes complications. Healthcare professionals ask the people in their care to test their blood glucose three or four times a day. Yet in many regions, very few people with diabetes have received education on how to adjust their insulin according to their blood glucose results.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:15
In November 2010, a pioneering team comprising a nurse educator, a dietitian and an endocrinologist from Singapore General Hospital completed a
DAFNE course and postcourse educator training in Australia, at the OzDAFNE centre, Diabetes Australia-Victoria. This was the first step in a process that successfully took the DAFNE model Singapore. The Clinical Leads for the Singapore initiative describe the experience so far and look to the future and continental development of their growing programme.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:12
Thirty-five years on from the demonstration that type 1 diabetes has an autoimmune basis, we have learned an enormous amount about the disease. We know its genetic basis (immune genes), its pathological basis (immune cells) and we would expect to be converting this insight into therapeutic advances (immunebased). Certainly, the field of immunotherapy for type 1 diabetesis very active. Here, Mark Peakman reviews the progress being made and scans the horizon for the mostlikely future breakthroughs.